These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 22749834

  • 1. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
    Tafaghodi M, Saluja V, Kersten GF, Kraan H, Slütter B, Amorij JP, Jiskoot W.
    Vaccine; 2012 Aug 03; 30(36):5341-8. PubMed ID: 22749834
    [Abstract] [Full Text] [Related]

  • 2. Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
    Slütter B, Bal S, Keijzer C, Mallants R, Hagenaars N, Que I, Kaijzel E, van Eden W, Augustijns P, Löwik C, Bouwstra J, Broere F, Jiskoot W.
    Vaccine; 2010 Aug 31; 28(38):6282-91. PubMed ID: 20638455
    [Abstract] [Full Text] [Related]

  • 3. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
    Pawar D, Mangal S, Goswami R, Jaganathan KS.
    Eur J Pharm Biopharm; 2013 Nov 31; 85(3 Pt A):550-9. PubMed ID: 23831265
    [Abstract] [Full Text] [Related]

  • 4. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener L, Huckriede A, Crommelin DJ, Jiskoot W.
    Vaccine; 2007 Jan 02; 25(1):144-53. PubMed ID: 16973248
    [Abstract] [Full Text] [Related]

  • 5. Antigen-adjuvant nanoconjugates for nasal vaccination: an improvement over the use of nanoparticles?
    Slütter B, Bal SM, Que I, Kaijzel E, Löwik C, Bouwstra J, Jiskoot W.
    Mol Pharm; 2010 Dec 06; 7(6):2207-15. PubMed ID: 21043518
    [Abstract] [Full Text] [Related]

  • 6. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally.
    Mangal S, Pawar D, Garg NK, Jain AK, Vyas SP, Rao DS, Jaganathan KS.
    Vaccine; 2011 Jul 12; 29(31):4953-62. PubMed ID: 21575664
    [Abstract] [Full Text] [Related]

  • 7. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.
    Int J Pharm; 2008 Nov 03; 363(1-2):139-48. PubMed ID: 18662762
    [Abstract] [Full Text] [Related]

  • 8. Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles.
    Borges O, Cordeiro-da-Silva A, Tavares J, Santarém N, de Sousa A, Borchard G, Junginger HE.
    Eur J Pharm Biopharm; 2008 Jun 03; 69(2):405-16. PubMed ID: 18364251
    [Abstract] [Full Text] [Related]

  • 9. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
    Jaganathan KS, Vyas SP.
    Vaccine; 2006 May 08; 24(19):4201-11. PubMed ID: 16446012
    [Abstract] [Full Text] [Related]

  • 10. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK, Tomar P, Sharma V, Dixit VK.
    Vaccine; 2011 Nov 08; 29(48):9026-37. PubMed ID: 21939718
    [Abstract] [Full Text] [Related]

  • 11. Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
    Slütter B, Soema PC, Ding Z, Verheul R, Hennink W, Jiskoot W.
    J Control Release; 2010 Apr 19; 143(2):207-14. PubMed ID: 20074597
    [Abstract] [Full Text] [Related]

  • 12. Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
    Hagenaars N, Verheul RJ, Mooren I, de Jong PH, Mastrobattista E, Glansbeek HL, Heldens JG, van den Bosch H, Hennink WE, Jiskoot W.
    J Control Release; 2009 Dec 03; 140(2):126-33. PubMed ID: 19712713
    [Abstract] [Full Text] [Related]

  • 13. Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
    Bal SM, Slütter B, Verheul R, Bouwstra JA, Jiskoot W.
    Eur J Pharm Sci; 2012 Mar 12; 45(4):475-81. PubMed ID: 22009113
    [Abstract] [Full Text] [Related]

  • 14. Preparation, characterization and in vivo evaluation of alginate-coated chitosan and trimethylchitosan nanoparticles loaded with PR8 influenza virus for nasal immunization.
    Mosafer J, Sabbaghi AH, Badiee A, Dehghan S, Tafaghodi M.
    Asian J Pharm Sci; 2019 Mar 12; 14(2):216-221. PubMed ID: 32104453
    [Abstract] [Full Text] [Related]

  • 15. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D, Jaganathan KS.
    Drug Deliv; 2016 Mar 12; 23(1):185-94. PubMed ID: 24825494
    [Abstract] [Full Text] [Related]

  • 16. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 17. Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations.
    Bal SM, Slütter B, van Riet E, Kruithof AC, Ding Z, Kersten GF, Jiskoot W, Bouwstra JA.
    J Control Release; 2010 Mar 19; 142(3):374-83. PubMed ID: 19932723
    [Abstract] [Full Text] [Related]

  • 18. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O, Silva M, de Sousa A, Borchard G, Junginger HE, Cordeiro-da-Silva A.
    Int Immunopharmacol; 2008 Dec 20; 8(13-14):1773-80. PubMed ID: 18801462
    [Abstract] [Full Text] [Related]

  • 19. Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization.
    Liu Q, Zhang C, Zheng X, Shao X, Zhang X, Zhang Q, Jiang X.
    Vaccine; 2014 May 07; 32(22):2582-90. PubMed ID: 24681230
    [Abstract] [Full Text] [Related]

  • 20. Lipopolysaccharide derived alginate coated Hepatitis B antigen loaded chitosan nanoparticles for oral mucosal immunization.
    Saraf S, Jain S, Sahoo RN, Mallick S.
    Int J Biol Macromol; 2020 Jul 01; 154():466-476. PubMed ID: 32194106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.